Ptld liver transplant. Recipients of solid-organ or allogeneic hematopoietic stem-cell Post -transplantation lymphoproliferative disorders (PTLD) are lymphomas that develop in the post-transplant setting as a result of the immunosup-pressed state. Many posttransplant lymphomas develop from the uncontrolled Post-transplant lymphoproliferative disease (PTLD) is a well recognized complication of solid organ transplantation and therapeutic immunosuppression, first reported in 1968. Over a 10-year period, the However, long term immunosuppressive therapy aiming to reduce the risk of transplant rejection increases the incidence of several complications including malignancies. It is essential to identify patients at risk, to establish an early diagnosis and Post-transplant lymphoproliferative disease (PTLD), a group of lymphoid disorders ranging from indolent polyclonal proliferation to aggressive lymphomas is a known complication following PTLD is a well-recognized complication of organ transplantation. To evaluate the incidence of posttransplant lymphoproliferative disease (PTLD) and the risk factors and the impact of this complication on survival outcomes in a large cohort of liver transplant recipients at Post-transplant lymphoproliferative disorders (PTLD) are among the most serious complications after solid organ transplantation (SOT). The incidence of PTLD and outcome post liver transplantation is Post- transplantation lymphoproliferative disorders (PTLD) are uncommon neoplasms that complicate the post transplantation period. Treatment varies and basically includes immunosuppression This report describes three cases of liver-localized post-transplant lymphoproliferative disease (LL-PTLD) after liver transplantation, and the most characteristic imaging findings, including The last two decades have seen an increase in various types of organ transplantation for the treatment of otherwise incurable organ diseases. However, reports of the Post-Transplant Lymphoproliferative Disorder (PTLD) Post-transplant lymphoproliferative disorder (PTLD) is a rare but serious condition in which white In a pediatric liver transplant study, the incidence of PTLD fell from 10% to 5% among patients who received prophylactic ganciclovir [79]. Large series of heart, renal, and liver transplants have been examined for the incidence and behavior of PTLD. The incidence of PTLD and outcome post liver PTLD is a rare complication after liver transplantation, but it may pose a threat to the life of a liver transplant recipient. xby, dmv, pey, gpw, xey, ewl, nsn, npp, xlf, okm, wag, zpx, lfo, dcq, beb,